Ondacetron injection site
Ondansetron (often misspelled "ondacetron") injection can be given IV or IM. For IV, it's diluted and given over 15 minutes; for IM, the deltoid or vastus lateralis are common sites.
Searching sources...
Reading File
Finding Sources
Searching the Web
ondansetron injection site administration IV IM routes
Finding Sources
Reading File
Here is a complete summary of ondansetron injection site and administration:
Ondansetron Injection - Routes and Administration
Available Injection Formulations
- 2 mg/mL solution for injection (most common)
- 4 mg/2 mL (2 mg/mL) single-dose vials
Routes of Administration
1. Intravenous (IV) - Most Common Route
Slow IV Injection (bolus):
- Inject undiluted over at least 30 seconds, preferably over 2-5 minutes
- Standard dose: 8 mg (adults) for CINV; 4 mg for PONV
IV Infusion (diluted):
- Dilute in 50-100 mL of compatible fluid (0.9% NaCl, 5% Dextrose, etc.)
- Infuse over 15 minutes
- Given 30 minutes before chemotherapy
Continuous IV Infusion:
- 1 mg/hour for up to 24 hours (maintenance)
2. Intramuscular (IM)
- Inject as a slow IM injection (not less than 30 seconds)
- Dose is the same as IV: 8 mg for CINV, 4 mg for PONV
- IM and IV formulations are the same preparation (no dilution needed for IM)
- Systemic exposure is equivalent between IM and IV routes (per pharmacokinetic data)
Common IM injection sites:
- Deltoid muscle (upper arm) - most commonly used in adults
- Vastus lateralis (outer thigh) - preferred when deltoid not accessible
- Ventrogluteal / dorsogluteal - less commonly used for this drug
Dosing by Indication
| Indication | Dose | Route | Timing |
|---|---|---|---|
| CINV prevention (adults) | 8 mg | IV (single dose) | 30 min before chemo |
| PONV prevention (adults) | 4 mg | IV or IM | At end of surgery |
| Radiation-induced N&V | 8 mg | IV or oral | Before radiotherapy |
| Pediatric CINV (BSA 0.6-1.2 m²) | 5 mg/m² | IV | Before chemo |
Key Points
- Do NOT give rapid IV push - risk of QT prolongation and hypotension; minimum 30 seconds
- Ondansetron causes small but significant QT prolongation (especially first-generation 5-HT3 antagonists); avoid in patients with prolonged QTc or on other QT-prolonging drugs
- Compatible with dexamethasone via Y-site infusion (often co-administered for enhanced antiemetic effect)
- Dose reduction may be needed in hepatic insufficiency (extensive hepatic metabolism)
- No dose reduction needed in renal impairment or elderly patients
Sources: Katzung's Basic and Clinical Pharmacology, 16th Ed. (p. 1717); Pfizer Prescribing Information; StatPearls - Ondansetron
Adult dose
Searching sources...
Finding Sources
Searching the Web
ondansetron adult dose injection IV IM complete dosing guidelines
Ondansetron Injection - Adult Doses
1. Chemotherapy-Induced Nausea & Vomiting (CINV)
| Regimen | Dose | Route | Timing |
|---|---|---|---|
| Standard (weight-based) | 0.15 mg/kg/dose x 3 doses (max 16 mg/dose) | IV infusion over 15 min | 1st dose 30 min before chemo; repeat at 4 hr and 8 hr |
| Fixed dose | 8 mg (slow IV or IM) | IV/IM | Immediately before chemo |
| Highly emetogenic chemo | Up to 32 mg/day total (in divided doses) | IV | Divided doses |
| Continuous infusion | 1 mg/hour | IV | Up to 24 hours |
Maximum single IV dose: 16 mg Maximum daily dose: 32 mg (0.45 mg/kg/day IV in 3 divided doses)
2. Post-Operative Nausea & Vomiting (PONV)
| Purpose | Dose | Route | Timing |
|---|---|---|---|
| Prevention | 4 mg | IV (over 30 sec - 2 min) or IM | At induction of anaesthesia |
| Treatment (established PONV) | 4 mg | IV or IM | Postoperatively |
- A second 4 mg dose does not provide additional benefit if the first prophylactic dose failed.
3. Radiation-Induced Nausea & Vomiting
| Situation | Dose | Route |
|---|---|---|
| Total body / abdominal irradiation | 8 mg | Slow IV or IM before each fraction |
4. Emergency Department / General Use
- Usual dose: 4-8 mg IV/PO as a single dose
- May go up to 16 mg as a single dose in non-elderly adults
- Elderly: initial dose should not exceed 8 mg, given as an infusion over 15 min
Dose Adjustments
| Condition | Adjustment |
|---|---|
| Severe hepatic impairment (Child-Pugh ≥ 10) | Max 8 mg/day (IV or oral) |
| Renal impairment | No dose adjustment needed |
| Elderly | Max 8 mg per dose; infuse over 15 min |
| Pregnancy (nausea/vomiting) | 8 mg IV over 15 min every 12 hr (third-line option) |
Summary in Brief
| Indication | Dose |
|---|---|
| CINV | 8 mg IV (or 0.15 mg/kg x 3) |
| PONV | 4 mg IV/IM |
| Max single IV dose | 16 mg |
| Max daily dose | 32 mg |
| Hepatic impairment | 8 mg/day max |
Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics (adult dose table: 8-16 mg IV); Rosen's Emergency Medicine (4-8 mg IV, up to 16 mg); DailyMed FDA label; Fresenius Kabi PI
This is a shared conversation. Sign in to Orris to start your own chat.